[[{“value”:”
The FDA rejected Novo Nordisk’s biologics license application for icodec, citing questions about the manufacturing process for this once weekly insulin as well as its use by type 1 diabetes patients. But there are several high-profile FDA approvals in our recap of recent regulatory news.
The post FDA Says ‘No’ to Novo Nordisk’s Once-Weekly Insulin appeared first on MedCity News.
“}]]
